Skip to main content
  1. Home
  2. Emerging Tech
  3. News

U.S. officials get tough on hoverboards, seize more than 16,000 counterfeit units

Add as a preferred source on Google

The U.S. authorities are getting tough on hoverboards, with the Customs and Border Protection (CBP) agency on Wednesday announcing it’d seized a record number of the self-balancing scooters for posing a serious health and safety risk.

Officers in Chicago confiscated 16,000 counterfeit boards worth an estimated $6 million in the raid, though the number is expected to run much higher due to the huge number of shipments still being processed.

Recommended Videos

The seized devices, many of which reportedly came from China, bear fake trademark logos and also contain batteries that fail to meet U.S. safety standards.

The hoverboard, which despite its name doesn’t really hover at all but instead uses wheels to move, was one of the holiday season’s biggest sellers. However, reports from around the world of sudden fires caused by dodgy lithium-ion batteries inside sub-standard models prompted many concerned retailers to pull the device from sale. Airlines, too, banned the board from flights.

The U.S. Consumer Product Safety Commission (CPSC) said recently it’d so far received reports of 39 hoverboard fires in 19 states.

An indication of just how serious the situation has become came last week when CPSC Chairman Elliot F. Kaye recommended hoverboard owners to keep a fire extinguisher with their machine at all times.

In its report outlining an ongoing investigation into the blazing boards, the commission said that many of the fires “occurred indoors and could have resulted in serious injuries if not for the quick actions of consumers to extinguish the fire.”

Commenting on the recent raid in Chicago, William Ferrara, CBP’s director of field operations, said, “Not only are these hoverboards a serious safety hazard but they also threaten our economic security by hurting legitimate businesses who invest significant amounts of resources into the development and protection of their brands.”

Reputable makers of the board will be desperately hoping the bad publicity soon fades away as counterfeit devices are gradually removed from the market, though it’s clearly going to take time for cautious consumers to be convinced of the product’s safety.

Trevor Mogg
Contributing Editor
Not so many moons ago, Trevor moved from one tea-loving island nation that drives on the left (Britain) to another (Japan)…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more